Amkay Products reported a 9.47% revenue increase to ₹42.03 crore for FY26. However, net profit dropped significantly by 30.78% to ₹2.31 crore, mainly due to rising expenses. The company also appointed an internal auditor and received an unmodified audit opinion.
Revenue from Operations: ₹42.03 crore (₹4,202.70 lakh) Profit for the Period: ₹2.31 crore (₹231.10 lakh) Reader Takeaway: Revenue growth offset by declining profit due to rising costs and pending account confirmations. ## What just happened Amkay Products Limited announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a revenue of ₹42.03 crore, marking a 9.47% increase from ₹38.39 crore in FY25. However, profitability saw a significant decline, with profit for the period falling by 30.78% to ₹2.31 crore, down from ₹3.34 crore in the previous year. Basic Earnings Per Share (EPS) also decreased to ₹2.67 from ₹3.96. The company's total expenses rose to ₹39.49 crore in FY26 from ₹35.41 crore in FY25, impacting the bottom line. Despite these challenges, the company received an unmodified audit opinion from its auditors. ## Why this matters The divergence between revenue growth and profit decline is a key concern for investors. While the company is expanding its top line, rising costs are eating into its profits. The unmodified audit opinion provides some reassurance regarding financial reporting, but the pending confirmations on trade receivables and payables highlight potential areas of uncertainty. ## The backstory Amkay Products Limited is involved in the manufacturing of healthcare and pharmaceutical products. The company has been focused on expanding its market reach and product portfolio. ## What changes now The company has appointed M/s. Soni Punit & Associates as its internal auditor for the fiscal year 2026-27, a routine governance step. Management also assessed new Labour Codes notified in November 2025 and found no material impact on operations. ## Risks to watch * **Profit Contraction:** The reported decline in profit despite revenue growth signals margin pressure. Investors should watch cost management. * **Pending Confirmations:** Note 7 in the financial statements indicates that trade receivables and payables are pending confirmation. This could lead to adjustments in the company's financial position. ## Peer comparison (No peer comparison data available in the filing) ## Context metrics (time-bound) * **Revenue Growth:** +9.47% in FY26 compared to FY25. * **Profit Decline:** -30.78% in FY26 compared to FY25. * **Basic EPS:** ₹2.67 in FY26, down from ₹3.96 in FY25. ## What to track next Investors should monitor Amkay Products' strategies for cost control, margin improvement, and resolution of pending account confirmations. The company's ability to manage expenses effectively will be crucial for future profitability.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
